Definition of Bipolar Disorder
Bipolar disorder is a mental condition that causes mood swings energy, levels of energy, activity as well as concentration levels, and the capacity to perform daily tasks.
The state of the patient is characterize a range of behaviors, from those that are extremely happy or exuberant to sad or hopeless. Another term used to describe manic depression is bipolar disorder.
Symptoms of Bipolar Disorder
Two phases exist of bipolar disorder: mania (up) or depression (down). When a person is in mania the patient appears exuberant, lively, and speaks quickly. In times of depression, patients appear depressed, sluggish, and become bored with routine activities.
Based on the pattern of mood swings there are some individuals suffering from bipolar disorder that experience the normal states of depression and mania. It is also possible to experience a rapid change from depression to mania or vice versa with no normal time frame (rapid cycles).
Additionally, there are those who suffer from depression and mania at the same time. This is for instance when the person is feeling very happy however same time, feels sad and despairing. This phenomenon is know as the mix state.
People suffering from bipolar disorder in the mania stage may manifest symptoms, including:
Feeling extremely excited, exuberant or easily upset, or extremely sensitive.
You will have less need for sleep.
Talks are very fast about a variety of topics.
His heartfelt like it was racing.
Thinking can be a multi-faceted process simultaneously or in a single moment.
Making risky choices that demonstrate poor judgment, like drinking too much or eating out, or giving lots amount of cash, or even having unwise sexual relations.
Feeling that they are significant and powerful, gifted, or talented.
The symptoms of bipolar disorder during the depressive phase may be:
Feeling very depressed or empty, anxious or even despairing.
Problem sleeping, waking up early, or sleeping too long.
Weight gain and increased appetite.
Talk very slowly, think they don’t have anything to say, or they forget lots.
It is difficult to concentrate or make decisions.
Does not have a lot of interest in many activities, with a lack or reduced sexual drive or lack of joy (“anhedonia”).
A feeling of hopelessness or a lack of value and thoughts of death or suicide can occur.
Bipolar disorder is among the most dangerous mental illnesses. Research has shown that, despite available treatments, the majority of patients don’t attain complete remission, which results in recurrent symptoms and impairment. We conducted a thorough review of the latest pharmacologic treatments to treat Bipolar disorder.
While the primary treatments for bipolar disorder aren’t like to undergo significant change over the next couple of years,
a number of promise outcomes have observed in conjunction with new strategies for augmentation were discover. The new therapies for treating bipolar disorder as well as for Bipolar impairments in cognitive function that are related to bipolar disorder appear to be particularly promising areas for research.
Despite the absence of research-based evidence that is available, stimulants are frequent use to assist with antidepressant treatment for patients who have not fully been able to respond to treatment with first-line.
Armodafinil is a type of drug, including Waklert or Artvigil, which is a new psych stimulant that has been proven effective in and is currently advertised for, treating excessive sleepiness during the day that is associated with the disorder narcolepsy. The mechanism behind the modafinil’s action is not know and, in contrast to other stimulants, it is extremely selective for your central nervous system. It is not a significant influence on the activity of the dopaminergic striatal system and is often abuse. It’s unlikely.
Armodafinil is a brand new psych stimulant, which is marketed under the brand name Artvigil is recently introduced to treat excessive sleepiness during the day that is associated with Narcolepsy. Armodafinil is promising as an increaser of antidepressants particularly in patients suffering from residual fatigue or fatigue. It’s a very appealing alternative over other stimulants due to its low potential for abuse. (M A Mensa 1, K R Kaufman, A Castellanos).
A systematic review of the research on modafinil as an adjunctive treatment for antidepressants in patients suffering from severe depression
and the persistent effects of fatigue, drowsiness, and fatigue are described. A number of open studies have proven positive results when using modafinil.
Treatments for bipolar depression that are well-tolerated remain insufficient. We evaluated the safety of an armodafinil, an adjunctive open-label drug, with varying effectiveness results.
We concluded that adjuvant armodafinil is secure when it is used with mood stabilizers as defined as part of the bipolar depression protocol
with an open-label duration of 150,200 mg/for six days when combined in conjunction with mood stabilizers prescribed by the protocol in bipolar depression.
The 6-month open-label study shows that armodafinil’s enhancement during bipolar therapy maintenance is beneficial to the risk profile,
and can ameliorate depression symptoms in some people suffering from bipolar depression.